via University of York
An international team of scientists have discovered a molecule which prevents tumour cells spreading from a primary cancer site to colonise other sites in the body.
The multidisciplinary research team, from the University of York, Leiden University and Technion (Israel Institute of Technology) discovered that the small, sugar-like molecule maintains the integrity of tissue around a tumour during cancer. They have shown the sugar-like molecules markedly reduce cancer spread in mice, paving the way for development towards clinical application.
Invade
Metastasis, the spread of cancer cells to distant sites in the body, is what makes cancer so lethal. Metastasis formation depends on the ability of cancer cells to detach from the primary tumour site, and invade through blood vessel walls and tissue barriers to reach secondary sites of growth. This metastatic invasion process requires biological molecules called enzymes, which digest proteins and sugars in the space around cells, enabling cancer cells to pass through the subsequent gaps.
One abundant class of sugar that surrounds cells are the heparan sulfates, which are long chain-like molecules that help stabilise the integrity of the extracellular space. Heparan sulfate sugars are digested by an enzyme called heparanase, which acts to chop up the ‘chains’ and thereby weaken the space around cells.
Target
Metastatic cancer cells produce large amounts of heparanase enzyme, which helps them to spread around the body. Inhibiting heparanase is therefore a major target for anti-cancer therapy.
The researchers developed and tested a new sugar-like molecular that reacts with the enzyme heparanase, whose 3-D structure was first solved by the York group. Once the new molecule is bound, the heparanase enzyme is unable to bind or cut heparin sugar chains around cells. In this way, the tissue around cells remains firm and inaccessible to dislodged cells.
At York, Professor Gideon Davies and Dr Liang Wu from the Department of Chemistry showed how the enzyme inhibitor inhibits heparanase. The research team is now looking at how the molecule can be further improved.
Evolve
Professor Davies said: “It has been brilliant to see the work develop from fundamental studies of enzyme structure and function and evolve into small molecules with potent anti-cancer activities. It is really exciting”
Researchers at Technion studied the new molecule in mouse models of lung cancer, breast cancer and blood cancer. While it is still too early to determine whether the new molecule will reach clinical application, the results are promising and the institutes involved have already applied for a patent on the molecule.
Safe
Lead author of the study Professor Hermen Overkleeft from Leiden University said: “Now we have to find out whether the compound is stable, safe for the human body, ends up in the right place in sufficient quantities, and so on. That takes a couple of years, it may come to nothing and someone has to be willing to take that financial risk.
“Our molecule is one of the few agents that can inhibit heparanase tightly and specifically. Medicine has a preference for small, simple molecules like this.”
Original Article: Chemists create molecule that prevents tumour cells from spreading
More from: University of York | Leiden University | Technion-Israel Institute of Technology
The Latest Updates from Bing News
Go deeper with Bing News on:
Metastasis
- Cancer Cells Spread When They Stop Recycling Waste
View full profile. Learn about our editorial policies. Guan and his team compared 171 genes that influence autophagy to study how they affect metastasis in a mouse model of breast cancer. By using ...
- Inside the Cellular Tug-of-War: What Drives Cancer’s Spread?
How cancer cells tug against each other determines whether they can migrate elsewhere in the body. Understanding how cancerous cells spread from a primary tumor is important for any number of reasons, ...
- Study sheds light on cancer cell 'tug-of-war'
Understanding how cancerous cells spread from a primary tumor is important for any number of reasons, including determining the aggressiveness of the disease itself. The movement of cells into the ...
- CYRI-B mediated macropinocytosis drives metastasis via lysophosphatidic acid receptor uptake
Pancreatic ductal adenocarcinoma carries a dismal prognosis, with high rates of metastasis and few treatment options. Hyperactivation of KRAS in almost all tumours drives RAC1 activation, conferring ...
- The Role of Tumor Microenvironment in Malignant Progression and Target Validation
The tumor microenvironment (TME) is a complex network encompassing several immune cell types like cancer-associated fibroblasts, endothelial cells, pericytes, and various other tissue-resident cell ...
Go deeper with Bing News on:
Inhibiting heparanase
- DPP-4 Inhibitors -- An Update on Alogliptin
Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...
- ACE Inhibitors and Protection Against Kidney Disease Progression in Patients With Type 2 Diabetes: What's the Evidence?
Although angiotensin-converting enzyme inhibitors are frequently used as antihypertensive agents to lower blood pressure and slow progression of nephropathy in patients with type 2 diabetes ...
- Breast Cancer Hormone Therapy Side Effects? What Helps
Many people who’ve had breast cancer take medications – tamoxifen or aromatase inhibitors – to help prevent the cancer from coming back. Doctors prescribe them for people with “hormone ...
- How do JAK inhibitors work for ulcerative colitis?
JAK inhibitors are oral medications that can help reduce the overactive immune response associated with ulcerative colitis (UC). UC is a type of inflammatory bowel disease (IBD) that causes ...
- Scientists find new ways to convert inhibitors into degraders, paving the way for future drug discoveries
Researchers have discovered ways to convert inhibitor-style targeted cancer drugs into small molecules known as degraders, which help destroy cancer-promoting proteins in cells. The scientists ...